Researchers have developed a therapy using genetically engineered brain cells that appears to prevent or reduce the formation of amyloid plaques in a mouse model of Alzheimer's disease. The treatment, which involves a single injection, has been shown to clear away dementia-related proteins in the brain. The extent of the reduction in amyloid plaques varies, with some reports indicating a 50% decrease, although the exact outcome is not consistent across all accounts.